Trivarx Ltd has released a press release.
Entitlement Issue Results and Shortfall Notification
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- Ilumen Successfully Completes First Commercial Program
- Converting Note & Non-Renounceable Entitlement Offer
- Exclusive Agreement Signed for ilumen Pilot Program
- Response to ASX Appendix 4C Query
- Medibio Provides Update on FDA Process
Later from TrivarX
- MEB Outsources Psychology Services in support of ilumen
- Sponsored Research Agreement with Humanitas University
- Regulatory and Commercialisation Strategy Update
- Response to Appendix 4C Query
- MEB Signs Compass Group to ilumen
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX